Euromarkets get busier and busier

Biotech companies soon will have a new European source of public capital: the New Market in Denmark. The Copenhagen Stock Exchange last week unveiled its plan to establish a specialized market to enable young growth companies to raise capital via a listing.

"The New Market is aiming at companies which directly or indirectly operate in growth-oriented sectors. Such sectors include the pharmaceutical industry, information technology and biotech companies," Jurgen Nilsen, assistant manager in the listing department, told BioCentury...